Cadrenal Therapeutics, Inc. Common Stock (NASDAQ: CVKD) last traded at $1.61, up 0.63% on the session. The quote above updates while this page is open; the figures below are drawn from Cadrenal Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cadrenal Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CVKD. Its market capitalisation is $5.74 million.
Valuation measures for Cadrenal Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.74M |
|---|---|
| Enterprise value | $4.85M |
| Price / book | 1.40 |
| Beta | 2.09 |
Trailing-twelve-month figures tagged in Cadrenal Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$11.54M |
|---|---|
| Return on equity | -282.13% |
| Cash | $2.39M |
Range and volume for CVKD over the past 52 weeks.
| 52-week high | $14.64 |
|---|---|
| 52-week low | $1.54 |
| Volume | 36.2K |
| Average volume | 70.3K |
| Previous close | $1.60 |
Dividend history for Cadrenal Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 1024.84% |
|---|---|
| Dividend per share (TTM) | $16.50 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.